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Chemistry

Studies on Dihydrofolate Reductase from Hog Thymus
( 6 1 pp.)
Director! Dr. Galen P. Mell
Dihydrofolate reductase has been purified about
1 , 0 0 0 fold v/ith an overall yield of Sf» from hog thymus

glands.
The purification procedure includes addition
of protamine sulfate, ammonium sulfate precipitation,
Sephadex G-lOO filtration, affinity chromatography on
methotrexate-Sepharose and Sephadex G-25 filtration.
The purified enzyme existed as a single electrophoretic
form and with a molecular weight 1 9 , 6 0 0 t
estimated by Sephadex G-lOO filtration.

000 as

The catalytic activity of the hog thymus reductase
was enhanced by chaotropic agents, such as salts and
urea, but was inhibited by p-chloromercuribenzoate over
the range 5 x 10~^ to 1 x 10” ^ M. Double pH optima,
one between pH 5.0 and 5-5 and another near pH 7.5 were
observed. The presence of salts changed the pH-activity
profile.
The degree of inhibition of hog thymus reductase
by methotrexate was dependent upon the pH.
Binding of
methotrexate to the enzyme was reversible.
The enzyme reaction follows a sequential mechanism.
Competitive inhibition was observed for NADP with res
pect to NADPH, whereas noncompetitive inhibition was
obtained for NADP with respect to dihydrofolate.
Some
kinetic constants were also determined.
iii
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CHAPTER I
INTRODUCTION
Background
In the last twenty years, our knowledge of the action
of the vitamin folic acid at the molecular level has
expanded greatly. Coenzyme derivatives of this vitamin
play an important role in various one-carbon transfer
reactions, such as amino acid metabolism, methyl group
biosynthesis and purine-pyrimidine base synthesis. These
studies on the function of folate coenzymes, carried out
in numerous laboratories, have been reviewed by Blakley
(1) and by Rader and Huennekens (2), Parallel studies
concerned with the biosynthesis of tetrahydrofdie acid,
the coenz^nne form of folic acid, indicated that synthesis
of the coenzyme may be the probable target site for the
clinically useful antifolate drugs. Also, evidence has
accumulated to indicate that a defect in tetrahydrofdate
biosynthesis might constitute one of the means whereby
the malignant cell proceeds to autonomous uncontrolled
replication (3). Therefore, interest in folate metabolism
has remained at a high level for the biochemist, the
geneticist and the clinician.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

The structure of folic acid (pteroylglutamic acid)
as shown below, consists of three portions (1 ) a substi
tuted pterin, (2) p-aminobenzoic acid, and (3) glutamic
acid. Naturally-occurring folate derivatives differ from
each other in regard to the number of glutamate residues
present in the molecule, the state of oxidation of the
pteridine nucleus, and the type and site of attachment
of one-carbon substituents,
COOH
I

CHo
I ^
CH2

C — N — CH — COOH
H

I_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 1 1 _ _ _ _ _ _ _ _ _ _ I I _ _ _ _ _ _ _ _ _ I
2-amino-4-hydroxy6-methyl pterin

p-aminobenzoic
acid

glutamic
acid

The antifolate drugs, aminopterin and amethopterin, are
structurally related to folic acid as indicated below.
These compounds have been used extensively in' the past in
the treatment of certain malignancies such as leukemia
and choriocarcinoma.
(pOOH

CH2
CHg
N —CH
H

aminopterin:

NHg

Rj>= H

amethopterin:

NH^

R2"

COOH
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The conversion of folic acid to its coenzyme form,
5 ,6 ,7 ,8-tetrahydrofolate (PH^^) involves a two-stage
reduction, with the intermediate formation of 7 ,8-dihydrofolate (PH^) (^.5)* Polic acid is reduced chemically to
PHg by hydrosulfite or to

by H^/Pd catalyst in glacial

acetic acid. Biosynthesis of

is catalyzed by dihydro

folate reductase (5. 6 ,7, 8-tetrahydrofolate :NADP** oxidoreductase, EC 1,5*1*3) in the presence of the coenzyme
NADPH (or NADH to a less extent) (Reaction 1). Dihydro
folate is the preferred substrate for the enzyme.
folic
NADPH
acid --------- >

_
7 ,8-dihydrofolate

NADPH
>

5,6,7,8tetrahydrofolate

(Reaction 1)

Tetrahydrofolate subsequently functions as an intermediate
carrier of a one-carbon group between donor and acceptor
molecule. The one-carbon unit may exist at the oxidation
level of formate, formaldehyde or methanol and is attached
to the PH^^ at either the N^ or N^^ position or bridged
between them. The metabolic interrelationships of the
various donors and acceptors of the one-carbon unit have
been discussed in a number of review articles (1 ,2 ,5-9 ).
A reaction involving FHj^ that has attracted considerable
attention because of its role in the formation of DNA, is
the synthesis of the methyl group of thymidylic acid.
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Although the coenzyme forms of

are required in many

reactions, synthesis of thymidylic acid stands out as the
most susceptible reaction to deprivation or antagonism of
the coenzyme in rapidly dividing cells. Support for this
belief comes from several studies reporting altered
nucleic acid metabolism in tissue deficient in folic acid
and vitamin

. Increased ratios of RNA/DNA and uracil/

thymine have been demonstrated in bone marrow cells from
patients v/ith megaloblastic anemia as compared with cells
from normal patients (10,11). Moreover, a reduced DNA
content has been observed in the intestine and liver cells
of rats fed a diet containing the folic acid antagonists
(12). Also, the sarcoma 180 tumors from mice (13,14) grown
in cell culture in the presence of the antagonists had a
reduced DNA content. Similar results have been shown in
bacteria (15»l6 ), yeast cells (16), viruses (1?) and
tissue culture cells (14,18,19). However, these altered
metabolic states can be corrected by treatment with folic
acid or vitamin

. These findings, therefore point to

an impaired synthesis of DNA as a major defect in folate
deficiency. Should purine synthesis constitute the ratelimiting reaction, one would expect to see an inhibition
of both KNA and DNA, since purines are common constituents
of both molecules.
The synthesis of the methyl group of thymidylate
appears to require higher substrate levels of FH^ than
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any of the other one-carbon transfer reactions in cells
undergoing rapid division. For example, the serineglycine interconversion occurs at approximately the same
rate in sprue patients severely deficient in FHj^ as in
normal patients (20). In contrast, thymidylic acid synthe
sis is greatly diminished in patients deficient in FH^.
On the other hand. Totter and Best (21) have shown that
formate incorporation into thymine is inhibited to a much
greater degree than formate incorporation into purines in
aminopterin-treated bone marrow cells in vitro.
Synthesis of thymidylic acid has been studied exten
sively in a number of laboratories. The reaction involves
the addition of a methyl group originating from the onecarbon pool through FHji^ to the

-position of deoxyuridylic

acid to form thymidylic acid as indicated in Reaction 2
below.
deoxyuridylic acid

+

C IQ

N-^,N

-methylene FHj^

thymidylic acid

+ FH^

>
(Reaction. 2)

In this enzyme-catalyzed reaction, FH^^ not only acts as a
carrier for the one-carbon unit but also furnishes the
reducing equivalents necessary to convert the methylene to
a methyl group. By using tritium labeled PH^, Friedkin (22),
Wahba at

(23), and Blakley at aT. (24) demonstrated

that the tritium was incorporated into the methyl group of
thymidylic acid. The use of methylenetetrahydrofolate
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specifically labeled with tritium indicated that it is
the tritium at position 6 which is transferred without
dilution (25).
Thus, for every molecule of thymidylic acid formed
one molecule of FH^ is oxidized to FH^. Since FH^ itself
is not active as a coenzyme, substrate levels of FH^
must be maintained in order for thymidylate synthesis to
continue. This can be achieved either by a constant
exogenous supply of FH^, or the regeneration of PH^ from
FHg. Evidence has been presented to indicate that the FH^
formed during the thymidylate synthesis reaction is iden
tical to the substrate of dihydrofolate reductase (26),
and the enzymic regeneration of FH^^ can be accomplished by
this enzyme (2?,28). Therefore, an inoperative dihydro
folate reductase would prevent cell replication by de
creasing the production of FH^ and thus prevent the con
tinuous generation of thymidylate. These metabolieally
interdependent reactions have been termed the "thymidylate
synthesis cycle" (29) (Figure 1).
Dihydrofolate reductase is the enzyme preferentially
attacked by the antifolate drugs (30-35)» although the
possible existence of other target site(s ) has not been
excluded. Therefore, thymidylate methyl formation would
be expected to be inhibited to a greater extent than other
FH^-mediated reactions in'which FH^ is not converted to FH^.
A diagrammatic representation of the action of antifolates
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Thymidylate

Deoxyuridylate

thymidylate
synthetase

7,8-Dihydrofolate
N^,N -Methylenetetrahydrofolate

NADPH + H
dihydrofolate
reductase

NADP
T etrahydrofolate
one carbon
donor

Figure 1. Thymidylate Synthesis Cycle
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in proliferating tissues is shown in Figure 2. It empha
sizes the increased thymidylate turnover in tissues with
increased DNA synthesis, and the key role played by di
hydrofolate reductase in this sequence. The consequences
of dihydrofolate reductase inhibition by these antifolates
is apparent.

General Aspects of Dihydrofolate Reductase
The distribution of dihydrofolate reductase in various
tissues has been summarized by Blakley (1). Generally, the
level of this enzyme in normal tissue is so low as to be
barely detected. However, a highly increased level of enzyme
has been detected from cells treated v/ith the folic acid
antagonists or in the antifolate drug-resistant cells.
Prearson e^

(36) reported a 2-6 fold increase in reduc

tase -activity in mouse embryo cells infected with SV 40 and
polyoma virus. Fischer (37), Hakala ejt

(38) 1 and Misra

et al. (39) reported independently that marked increase of
dihydrofolate reductase levels was found in mouse leukemia
cells and sarcoma 180 cells which have become resistant to
amethopterin. Antifolate drug-resistant strains of bacteria
also showed higher activity in dihydrofolate reductase as
compared with the sensitive strains (4o,4l).
Dihydrofolate reductase is present in traces, if at
all, in leucocytes from normal patients or those with
chronic lymphatic leukemia, but it is present in significant
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antifolate
drugs
FHp
reductase
amino acid
metabolism

NADPH
FHp
reductase
Folic Acid.
NADPH

FH

methyl group
biosynthesis
purine base
synthesis

thymidylic acid
synthesis
V

DNA synthesis
V
cell division

Figure 2. Action of antifolate drugs in proliferating
tissues. Wavy lines indicate the site of inhibition.
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amount in leucocytes from patients with acute leukemia or
with infectious mononucleosis or with chronic myelogenous
leukemia (30,42-4^).
Dihydrofolate reductase has been isolated and par
tially characterized from a variety of sources. Different
molecular weights of this enzyme have been reported and
can be grouped into three general categories;
(1) 15,000-22,000 range for the enzyme from bacterial
sources (46-48), L1210 R cells (antifolate drugresistant strain) (49), chicken liver (50)» Ehrlich
ascites tumor (51)» and human leukocytes (52).
(2) 28,000-33,000 range for the enzyme from Streptococcus
faecium (48), Escherichia coli phage (53)* and calf
thymus (54).
(3) greater than 100,000 for the enzyme from Plasmodium
berghei (55)* Diplococcus pneumonii (56), and several
protozoa (57)*
The enzymes from bacterial sources within the first two
categories show a single pH optimum, and can not be acti
vated by chaotropes or by agents that react v/ith sulfhydryl
groups. Reductases from the other sources have double pH
optima and can be activated by chaotropes or mercurials
under some circumstances. A wide variation is also seen in
the

values for the substrates, FH^ and NADPH.
Mention should also be made about the binding of the

antifolate drugs to dihydrofolate reductase. Werkheiser (5^)
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has indicated that the binding capacity of tissues for
aminopterin is directly related to their dihydrofolate
reductase content. The toxicity of the drug also correlated
well with the degree of binding to the enzyme, and it was
diminished by prior injection of folic acid, probably by
interfering with the binding of aminopterin to the reduc
tase. Contradictory results concerning the kinetics of
inhibition of dihydrofolate reductase have been reported
{30,32,3^,39158-66). The type of kinetic behavior may
depend upon the source of the reductase, the substrate used
and the conditions, particularly the pH, used in the
experiment. As summarized by Blakley (1), inhibition by
amethopterin with folate as substrate is stoichiometric
with all reductase preparations. With reductase from most
animal sources, the inhibition has been described as
stoichiometric or noncompetitive or both, especially at
low pH. At higher pH, inhibition by the drug with FH^ as
substrate is often intermediate between that expected of
a stoichiometric inhibitor and tha.t exhibited by a compe
titive inhibitor. Reductase from bacterial species shows
similar variation' in the type of inhibition observed with
amethopterin depending on the substrate, and the pH of the
system.
Over the years a growing body of evidence has shown
that there are species differences in the reductase's
properties which may be important in determining the
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therapeutic usefulness of certain drugs. Therefore, the
selective chemotherapeutic action against certain abnormal
cells seems to be related to differential uptake of the
drugs by cells and also to different structural and cata
lytic properties of dihydrofolate reductase.
Although there have been many groups investigating
dihydrofolate reductase, the most well known structural
features of this enzyme were obtained from the bacterial
and avian systems. During the last several years, investi
gators have moved toward the mammalian system hoping to
increase our understanding of the mechanism of dihydro
folate reductase catalyzed reactions in higher organisms.

Thesis Objectives
Hog thymus was chosen as the source of dihydrofolate
reductase in this study for the reasons that none of the
reductase's properties were known and studies on thymidy
late synthetase from this source v/ere in progress in this
laboratory. Besides, thymus glands could be obtained
readily from a local slaughter house when this study was
begun.
The objectives of the present investigation were :
(1) purification of dihydrof olate reducta.se from hog
thymus tissue,
(2) characterization of this enzyme and comparison with
those from other sources, and
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(3) if possible, elucidation of the mechanism of this
enzyme-catalyzed reaction.
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CHAPTER II
MATERIALS AND METHODS

Materials
The following chemicals were obtained commercially»
Folic acid, (d ,1)L-tetrahydrofolic acid, protamine sulfate,
3~ (4 ,5-d.imethylthiazoyl-2)-2 ,5-diphenyltetrazolium bromide
(MTT-tetrazolium), NADPH, NADP, 2-mercaptoethanol, and
Trizma base (Tris) (Sigma); Sephadex G-lOO, G-25, and
Sepharose 4b (Pharmacia)j ammonium sulfate (J.T. Baker
Chemical Co.)? standard protein kit for molecular weight
determination (Schwarz/Mann), Methotrexate was a gift from
Dr. Larson in the Microbiology Department, University of
Montana.
FHg was prepared from folic acid by chemical reduction
v;ith hydrosulfite according to the method of Blakley (67,
68). The dried powder was stored frozen under vacuum in
sealed vials. A solution of 2.0 x 10”^ M FH^ (^282~ 28,000
M“"cra''^) v/as prepared in O .05 M Tris buffer, pH 7.2,
containing 0.01 M 2-mercaptoethanol. NADPH of 2.6 x 10”^ M
was prepared in the same buffer but without mereaptoethanol.
Dialysis tubing (Union Carbide Corp.) was washed by
heating at 60-70° C for one hour in 0.1 M 2-mercaptoethanol,
followed by repeated rinsing with distilled water, and was
o

stored in distilled water at 4 C.
14
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Methods
Standard Spectrophotoinetric Assay.

Dihydrof olate

reductase was measured according to the spectrophotometric
method of Osborn £t

(64), The reaction rate was

followed by measuring the decrease in absorbance at ])40 nm
by using a Gilford multisample absorbance recorder (set at
0-0.560 full scale) equipped with a constant temperature
O
water bath at 37 C. The following components were added
to a 1.0 cm cuvette I 0.05 i»l of 2.6 x 10”^ M NADPH, enzyme
and 0.05 M Tris buffer, pH ?,2. After a 5 minutes incuba
tion period at 37°C, 0.05 ml of 2.0 x 10”^ M FH^ was added
to initiate the reaction. The total volume of reaction
mixture was 1.2 ml. FHg or NADPH v/as omitted from the
appropriate blank. During reduction of dihydrofolate, both
FHg and NADPH disappearance cause a decrease in absorption
at 340 nm ( ^4o,NADPH~ 6.2 x 10^ M cm , ^34o,FH^~
3 M”
— 1cm~
—X ) . Therefore the observed
' absorption change
X 10-^
was corrected for disappearance of NADPH alone.
Modified Spectrophotometric Assay .

The kinetic

studies were done with the Cary I5 recording spectrophoto
meter, The reaction rate was measured by following the
decrease in absorbance at y^O nm for 5 minutes at room
temperature against the appropriate blank. The reaction
mixture (total volume 30*20 ml) contained NADPH, enzyme,
the assay buffer, and FH^ in a cylindrical cuvette with
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a 10.0 cm light path. In the product inhibition study,
different levels of NADP or

were also included. Either

FHg or NADPH was added to initiate the reaction. One unit
of enzyme activity is defined as the amount required to
reduce 1 Aimole of

per minute under the assay conditions,

Specific activity is expressed as units of enzyme per mg
of protein. Protein was determined by the Lowry method
(69), using bovine serum albumin as the standard.
Preparation of the Chromatographic Materials.
Sephadex G-lOO and G-25 was allowed to swell for 24 hours
in 0.05 M potassium phosphate buffer, pH 7.5» then washed
wi^h an additional 0.5 to 1.0 liter of buffer. After each
use the Sephadex was removed from the column, washed
extensively with water, and reequilibrated with phosphate
buffer. When not in use for an extended period of time,
the gel was stored in phosphate buffer containing 0.02 fa
sodium azide.
Preparation of Substituted Agarose. The following
procedure was the modified method of Whiteley _et

(70).

Sepharose 4b (wet-volume 25 ml) was washed with water to
remove sodium azide. The washed Sepharose was activated
at room temperature by the addition of 25 ml of cyanogen
bromide (100 mg/ml). The mixture was adjusted to pH 11.0
with 4 N NaOH and maintained at this pH for 10 minutes.
The suspension was filtered rapidly on a Buchner funnel
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and the residue was washed with 250 ml of ice-cold 0.1 M
NaHCO^, pH 9 .0 . The gel was resuspended in cold 0.1 M
NaHGO^, pH 9.0» and 5 ml of 1.0 M 1,6-hexanediamine was
added with stirring to the suspension. The washing and
the addition of the diamine was completed in less than 90
seconds. After mixing gently for 24 hours at 4° G, the
suspension was filtered and the residue was washed thor
oughly, first with buffer and then with water. The result
ing io-aminohexyl derivative of Sepharose was resuspended
in 25 ml of water and to it was added 58 mg of methotrexate
dissolved in 5 ml of H^O and 500 mg of 1-ethyl-3-(3-dimethylaminopropyl) carbodilmide at pH 6 .5 . The mixture was
stirred for 3 days at room temperature to ensure complete
coupling of the methotrexate to the insoluble modified
Sepharose. The bright yellow gel was recovered by filtration
and v/ashed successively with water, 0.1 N NaHGO^, water,
0.1 N NaOH, water, 0.1 N HGl and finally with water until
the resulting filtrates were colorless. The final product
was stored as an aqueous suspension in the cold and pro
tected from light. The amount of methotrexate coupled with
the Sepharose was determined spectrophotometrieally by
subtracting the amount recovered in the combined washings
from that initially present. About 1 rag of methotrexate
(2.2 X 10"^ mole) v/as found to be coupled per ml of wet
Sepharose.
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Purification of Dihydrofolate Reductase from Hog
Thymus.

Hog thymus tissue v/as purchased from John R.

Daily Co., Missoula, Montana. The tissue was placed in ice
as soon as possible after the animals had been slaughtered.
Centrifugations were performed in a Sorvall refrigerated
centrifuge, Model RC2-B, using the GSA rotor at 12,000 rpm
(23,300

X

g). In the chromatographic steps, fractions were

collected automatically by a Gilson Escargot fraction
collector. Unless stated otherwise, all purification steps
were performed at 0-5°C.
Step 1 .

Homogenate.

Fresh hog thymus glands (about 900

gi-Tims) were trimmed, cut into small pieces, and homogenized
in three volumes of O .05 M phosphate buffer, pH 7.5, con
taining 0.001 M EDTA and 0.15 M KGl in a waring blender
for a total of 75 seconds. The homogenate was centrifuged
for 40 minutes and the pellet was discarded.
Step 2 .

Protamine sulfate precipitation.

About 0.1 volume

of 5 ^ protamine sulfate was added to the supernatant fluid
from Step 1. The mixture was stirred for an additional 15
minutes, centrifuged, and the pellet was discarded.
Step 3.

Ammonium sulfate precipitation.

Solid ammonium

sulfate v/as added slowly with stirring to the protamine
sulfate supernatant to 65 % saturation (430 g/liter). After
the ammonium sulfate had dissolved, the suspension was
stirred for an additional I5 minutes, adjusted to pH 7.0,
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centrifuged for ^5 minutes, and the pellet was again
discarded. The supernatant fluid was brought to 90 fo
saturation with solid ammonium sulfate (190 g/liter),
mixed for 15 minutes, adjusted to pH 7.0, and centri
fuged for 45 minutes. The pellet was dissolved in a
minimum amount of 0.05 M phosphate buffer, pH 7-5. The
65-90 % ammonium sulfate fraction was dialyzed for two
and half hours against two 2-liter changes of 0.05 M
phosphate buffer, pH 7 .5 . Any insoluble material was
removed by centrifugation for 20 minutes.
Step 4 .

Gel filtration through Sephadex G-100.

Sephadex G-100, preequilibrated with O .05 M phosphate
buffer, pH 7.5, was added to a 5 cm column to a height
of 54 cm, and washed with 500 ml of buffer. Approximately
one-half of the dialyzed 65-90 fo ammonium sulfate fraction
was added to the column at one time and eluted with
phosphate buffer. Flow rate was 40-60 ml/hr and fractions
of 8 ml per tube were collected. Protein fractions con
taining reductase activity (tubes 6I-76 in Figure 3) from
the tv;o column operations were combined together.
Step 5.

Affinity chromatography.

The pooled enzyme

fraction (about 3OO ml) from Step 4 was applied to a 2 x
16 cm column of methotrexate-Sepharose (bed volume 55 ml)
preequilibrated with O.O5 M phosphate buffer, pH 7.5* Flow
rate was 30-40 ml/hr, and fractions of 6 ml were collected.
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Figure 3. Filtration of FH^ reductase, post ammonium
sulfate fraction, on Sephadex G-100. Conditions des
cribed in text.
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Nonadsorbed protein was washed from the column with an addi
tional 50 ml of the starting buffer. The column was then
washed with 100 ml of 0.10 M phosphate buffer, pH 8 .5 ,
followed by 200 ml of the same buffer containing about
10”^ M PH2 to facilitate elution of dihydrofolate reduc
tase. The pooled enzyme fraction (tubes 64-69 in Figure 4)
was then concentrated in an Amicon ultrafiltration appa
ratus equipped with a PM-10 membrane, or by overlaying
with sucrose. If the absence of FHg was not absolutely
necessary in subsequent studies, this sample was kept
frozen at pH 6.5 until further use.
Step 6 .

Gel filtration through Sephadex G-25.

PH^ was

removed from the concentrated enzyme fraction from Step 5
by filtration through a 2.5 x 28 cm Sephadex G-25 column
preequilibrated with 0.10 M phosphate buffer, pH 8.5*
(flow rate 20 ml/hr); fractions of 1.5 ml were collected.
The fractions containing enzyme activity (tubes 20-34 in
Figure 5) were pooled, and concentrated by either pressure
ultrafiltration or by sucrose concentration as described
above, and stored in the freezer for further use.
Microzone Electrophoresis.

Dihydrofolate reductase

was applied to a cellulose acetate membrane and subjected
to electrophoresis at 450 volts for 50 minutes in a
Beckman Microzone Cell, Model R-101. The buffer was 0 .I3 M
Tris-O.071 M borate, pH 8,6, containing 3 x lO” ^ M EDTA,
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Figure 4. Affinity chromatography of FH^ reductase, post
G-100 fraction, through methotrexate-Sepharose. Conditions
described in text. Buffer was changed to 0.1 M phosphate,
pH 8.5 at arrow A. Enzyme was eluted with the above buffer
containing 10 -4 M FHg at arrow B.
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Figure 5- Filtration of FH^ reductase, post methotrexateSepharose fraction, through Sephadex G-25. Conditions
described in text.
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Protein was located with 0.2 ^ Ponceau-S stain (Beckman
fixative dye solution), and the cellulose acetate membrane
was destained with 5 ^ acetic acid. Enzyme activity was
detected by the method of Gunlack at

(71) as modified

by Mell et a^. (?2). Special Agar-Noble (135 mg) was
dissolved with heating in 5 ml of 0.1 M Tris buffer, pH
7.5* When the agar had cooled to about 70° G , the follov/ing
substances were added; MTT-tétrazolium (2.5 mg/2.5 ml of
0,10 M Tris, pH 7.5) , NiADFH (2.5 mg/o.5 ml of the same
buffer), and mercaptoethanol-free FHg (1.5 mg/O.5 ml of
the same buffer). The resulting mixture was poured quickly
into a shallow, rectsngular tray end allowed to solidify=
The cellulose acetate membrane after electrophoresis, was
placed on the agar and allowed to stand at 37° G in an
incubator. Appearance of violet spots indicated existence
of dihydrofolate reductase. An agar plate containing 5 x
10“^ M methotrexate in addition to the other above reactants
was used to confirm the presence of dihydrofolate reductase.
Molecular Weight Determination.

The molecular v/eight

of dihydrofolate reductase was estimated by filtration
through a 2 X 88 cm column of Sephadex G-100 (bed volume
I50-I60 ml, flow rate 18 ml/hr) by a modification of the
method of Whitaker (73)* The column v/as equilibrated with
0.05 M Tris buffer, pH 8.4, and calibrated by adding
separately six standard protein solutions (2-5 mg protein/
1 ml of the above buffer). Fractions of 1.5 mil were
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collected. Elution volume for a given protein was calcu
lated from the maximal point of its elution peak. The
void volume of the column was determined by measuring
the elution volume of Apo-Ferritin, an amorphous protein
with molecular weight 480,000 daltons.
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CHAPTER II
RESULTS
Assays of Enzyme Activity
The spectrophotometric assay for dihydrofolate
reductase activity was used throughout this investigation.
Relatively large blank corrections were observed in the
early stages of purification, i.e. the tissue homogenate
and post protamine sulfate fraction. These early enzyme
fractions should be as free as possible of particulate
material to prevent interference in the assay mixture.
Unless stated otherwise, the spectrophotometric assay
was performed at 37°G since the enzyme was present in
small amounts in the tissue.

Purification Procedure
About 15 enzyme preparations were made in the course
of this study. Typical results of the purification proce
dure are summarized in Table 1. The enzyme was purified
approximately 1,000 fold with an overall yield of 5

The

protein value for the post MTX-Sepharose and Sephadex G-25
fraction is not available due to the low concentration of
protein and the presence of FH^ and mereaptoethanol in the
Sepharose fraction which interfered v/ith the Lowry assay.
Considerable loss of enzyme activity was observed following
26
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TABLE 1

PURIFICATION OF DIHYDROFOLATE REDUCTASE
FROM !391 g OF HOG THYMUS GLANDS

Fraction
(ml)

Reductase
Activity
(units)

Specific
Protein Activity Recovery
(mg)
(units/mg)
(^)

Tissue
Homogenate

1630

51

68,000

0.00075

Protamine
Sulfate

1620

39

39,000

0.0010

76

90

24

6,300

0.0038

47

Sephadex G-100

316

17

1,900

0.0089

33

MTXSepharose

344

13

Sephadex G-25

123

5.7

Concentration
with Sucrose

23

2.5

Dialyzed 6590fo Ammonium
Sulfate

100

26
11
3.3

0.76
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precipitation of protein with ammonium sulfate. Little or
no enzyme activity was found in the 35-^5 % ammonium sul
fate fraction. About I3 % of the activity was not precipi
tated from the solution by adjusting to 90 % ammonium
sulfate which at 0-5°G represents a nearly saturated
solution. Therefore, inherent instability of dihydrofolate
reductase itself and incomplete precipitation with ammonium
sulfate account for the low yield. The most striking in
crease (abut 80 fold) in specific activity occurred fol
lowing affinity chromatography on MTX-Sepharose.
In the earlier experiments, the Sephadex and Sepharose
fractions were concentrated by pressure filtration, but
significant loss of enzyme activity was observed. It was
later found that concentration of the protein samples by
the sucrose method resulted in improved recovery of enzyme
activity.
In terms of stability of the hog thymus enzyme, 50
of its activity was lost by storing at 4°C for one week at
either pH 7*5 or pH 8.5 . However, no significant loss of
enzyme activity v/as found when it was kept frozen for
several months. The addition of NADPH or EDTA to the enzyme
solution did not help to stabilize the enzyme at 4°C.

Electrophoresis Results
Purity of the final enzyme fraction, as well as the
possible presence of multiple forms of dihydrofolate
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reductase, was investigated by electrophoresis on cellu
lose acetate. Unfortunately, the concentration of protein
in the purified enzyme preparation was so dilute that no
protein bands were visualized when the electrophoretogram
was stained with Ponceau S dye. Thus, the protein hetero
geneity of the sample is unknovm.
The purified hog thymus enzyme preparation showed a
single form of dihydrofolate reductase on cellulose acetate,
whereas reductase purified from chicken liver existed as
multiple forms. As shown in the drawing below, the hog
thymus enzyme moved faster than the minor fast-moving form
of the chicken liver enzyme. No enzyme activity in either
preparation was detected on the electrophoretogram v/ith
5 X 10“^ M MTX present in the staining mixture.

chicken liver
reductase
hog thymus
reductase
origin

Molecular Weight
Dihydrofolate reductase from hog thymus has a molecular
weight of 19,600 t 3,000 as determined by filtration'through
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Sephadex G-100 (Figure 6). The deviation range was derived
by using the Equation for Confidence Interval for Single
Additional Observation (7^). Thus, the enzyme from hog
thymus tissues has a molecular weight similar to that
reported for 1,1210 R and chicken liver enzyme (category 1,
p.10).

Effects of Chaotropic Agents and p-Chloromercuribenzoate
Some but not all dihydrofolate reductases are activated
by chaotropic agents,

i.e. salts and urea, and by certain

organic mercurials which are known to alter the secondary
or tertiary structure of proteins in aqueous solution.
Potassium chloride and ammonium sulfate activated the hog
thymus reductase as presented in Figure 7. Maximal acti
vation was achieved at 0.7 M KOI and at 0.1 M (NHj^)2S0^.
The reductase was activated approximately 2.5 to 3
fold by 3 M urea as shown in Figure 8. Higher concentrations
of urea resulted in loss of enzyme activity.
The hog thymus enzyme was not activated by p-chloromercuribenzoate (pCMB) over the concentration range 10”^
to 10“ ^ M (Figure 9). At concentrations greater than 5 x
10"^ M the mercurial inhibited enzyme activity. In contrast,
the mercurial gives a 4 fold increase in enzyme activity for
the dihydrofolate reductase purified from Ehrlich ascites
cells (75 »76 ) and chicken liver (77).
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Figure 6. Molecular weight estimation of FHg reductase
on Sephadex G-100. Conditions described in text. To the
column was added 2.5 ml of a post MTX-Sepharose enzyme
fraction (0.24 units/ml, A2 q q = 1.480). Dashed line indi
cates the value for FH^ reductase.
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Figure ?. Activation of FH^ reductase by potassium
chloride (x) and ammonium sulfate (<=>), Standard
spectrophotometric assay conditions were performed,
except the assay buffer contained the indicated
concentrations of KGl or (NH^)2S0^.
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Figure 8. Activation of FH^ reductase by urea. Urea was
added to the standard assay to give the indicated con
centration.
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Figure
Inhibition of FHg reductase by p-chloromercuribenzoate. Standard assay conditions, except pCIVlB was
added to give the indicated concentrations and FHg was
freshly prepared in the absence of mercaptoethanol.
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pH Optimum
The activity-pH profile of dihydrofolate reductase
showed two optimal values, one between pH 5*0 and 5*5»
and another near pH 7.5 as indicated in Figure 10. Enzyme
activity was slightly higher at the alkaline pH optimum.
More enzyme activity was observed in phosphate than in
acetate buffer.
In the presence of KGl, the enzyme activity-pH profile
(Figure 11) remained similar in the acid range to that
observed in the absence of salt, whereas the pH optimum
at 7*5 appeared to be shifted to 8.4. On the other hsind,
in the presence of (NHj^)^SO^, the enzyme had relatively
constant activities from pH 6.0 to 9.0.

Inhibition by Methotrexate
Hog thymus dihydrofolate reductase, like its counter
part from other sources,

is extremely sensitive to the anti

folate drug methotrexate. As shown in Figure 12, at pH 7.2,
a drug concentration of 10”
greater than 50

%

M was sufficient to cause

inhibition of enzyme activity. At pH 6.5

and 8.4, the inhibition by the drug was about 30

%

and 20

respectively. Inhibition of reductase activity leveled off
at 80 % with concentrations of methotrexate greater than
—

5 X 10“

8

M. Inability to achieve 100

fo

inhibition has been

observed also in lÆTX-resistant cells of mouse leukemia
L4946 (78) and Diplococcus pneumonii (79).
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Figure 10. The pH optimum for FHg reductase. The Tris
buffer in the standard spectrophotometric assay was
replaced with the following buffers at the indicated
pHi 0,05 M sodium acetate ( x ) ;

0.05

M

potassium phos

phate (o)î and 0.05 M Tris (*). The blank for results
below pH 6.5 contained NADPH and F H g , but no enzyme to
account for the acid degradation of coenzyme.
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Figure 11. Effect of KOI and (NH^)
the pH optimum
of FHg reductase. Conditions were the same as for Figure
10, except in the presence of 0,64 M KOI (------ ) or
0.09 M (NH^)gSO^ (------ ).
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Figure 12 . Inhibition of PHg reductase by methotrexate,
Inhibition was measured at pH 6.5 (x); pH 7.2 (o); and
pH 8.4 (A ). Methotrexate present in the assay buffer
was incubated with enzyme and NADPH for 5 minutes at

37° C. FHg was added to the solution to initiate the
reaction.
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Initial Velocity Studies
The reaction mechanism of dihydrofolate reductase
was studied by using the kinetic analysis devised by
Cleland (80). This approach involves measurement of the
initial velocity of the reaction at varying concentrations
of one substrate and at different fixed levels of the
second substrate. A plot of reciprocal velocity versus
reciprocal concentration of variable substrate gives a
series of linear lines intersecting to the left of the
vertical axis with a sequential mechanism» i.e. both
substrates react with the enzyme before any product is
released. If the initial velocity pattern is a series of
parallel lines, a pingpong mechanism is suggested in
which one substrate is

bound to and one product is re

leased from the enzyme

prior to the addition of the

second substrate.
As shown in Figures 13 and l4, when the initial velo
city data were plotted with NADPH or FH^ as the variable
substrate, a family of nonparallel lines, consistent with
a sequential mechanism, was obtained. If the slope and
intercept in Figure 14 were then plotted against the
reciprocal concentrations of
substrate, the replots

NADPH, the changing fixed

were linear. The Michaelis con

stants and dissociation constant calculated from these
data are presented in Table 2. Nonlinear replots were
obtained in the case of F H ^ .
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Figure I 3 . Effect of FH^ on the initial velocity of
FHg reductase with NADPH as the variable substrate.
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Figure 14, Effect of NADPH on the initial velocity of
FHg reductase with FH 2 as the variable substrate.
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TABLE 2

KINETIC CONSTANTS

Kinetic Constant

^NADPH

Value
(aim )

0.6
0.8

‘'i PHg

2.3
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Product Inhibition Studies
Since there are a number of possible sequential
mechanisms (81), i.e. ordered, Theorell-Ghance, or rapid
equilibrium type, product inhibition studies by both NADP
and

were carried out with respect to each substrate

to distinguish between these mechanisms. However, experi
ments with FH^ as the product inhibitor were not success
ful due to the instability of FHj^ itself. Concentrations
of mercaptoethanol greater than 0.1 M in the assay
mixture might have overcome this difficulty; however, the
small amount of purified enzyme and the lack of time did
not allow me to repeat this portion of the study.
A pattern of competitive inhibition was obtained by
the product NADP with respect to NADPH (Figure 15)* Non
competitive inhibition was observed by NADP with respect
to FHg (Figure 16), Replots of slope or intercept in
Figures 15 and 16 versus concentrations of NADP resulted
in a nonlinear relationship. Proper interpretation of the
nonlinear replots requires further experimentation.
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Figure 15. Inhibition of FH^ reductase by NADP with NADPH
as the variable substrate.

(FHg] was fixed at 6.6 /uM.
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Figure 16. Inhibition of FHg reductase by NADP with FHg
as the variable substrate, (n a d p h ) was fixed at 12,9 yuM.
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CHAPTER IV
DISCUSSION
Dihydrofolate reductase has been purified approximately
1,000 fold from hog thymus glands. Affinity chromatography
is the most effective step in the purification procedure.
This technique exploits the specific reversible interaction
between ligand and biopolymer (82). The method (83,84) con
sists of coupling covalently a spacer group, 1 ,6-hexanediamine to agarose activated by cyanogen bromide. Metho
trexate was coupled to the terminal amino group of the
spacer compound via its carboxyl groups by means of a carbodiimide condensation reaction. It has been shown that the
coupled methotrexate retains its ability to bind to FH^
reductase (83). Thus, methotrexate covalently attached to
the insoluble gel was able to adsorb the reductase from
solution. Methotrexate interacts with the enzyme much less
strongly at alkaline pH as presented earlier in Figure 12,
therefore, the methotrexate-enzyme complex was dissociated
by changing the pH of the buffer. FHg is included in the
alkaline buffer to further promote dissociation of the enzymeinhibitor complex. In the present study, about an 80 fold
purification of the enzyme was achieved in this single step
(Table 1). A nearly 4,000 fold purification of FHg reductase
46
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was reported from rat skin by this technique (84).
Additional purification steps were explored, such as
fractionation with ethano1-chloroform mixture and precipi
tation of proteins and nucleic acids at pH 5*4, but none
of these methods were found successful.
Specific activity of the purified hog thymus enzyme
was similar to values reported for the reductase from some
other animal sources (4,51,52,61,85.86). The presence of
multiple forms of the reductase in purified hog thymus
preparations could not be detected by electrophoresis on
cellulose acetate. In contrast, the purified chicken liver
enzyme (72) and that from L. casei R (4?) were reported to
exist in several forms. The multiple forms were interconvertable depending on the amount of NADPH bound to the
protein. The thymus enzyme migrated about one-third faster
than the fastest moving enzyme form from chicken liver.
Therefore, the hog thymus enzyme as compared with the chicken
liver enzyme may differ in amino acid content, the number of
amide groups, and hence the net charge existing in the protein
molecule.
The molecular weight of the hog thymus enzyme is appro
ximately 20,000, which falls into category 1 on page 10. The
reductases in category 3 have a molecular weight greater
than 10^. The possibility that they might be composed of
subunits or associated with some other protein or nucleic
acid awaits further investigation. Amino acid analyses
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have been reported for the chicken liver enzyme (87) and
the enzyme from L. casei R (88) and L1210 R cells (89),
but there is no evidence at present that any of the FHg
reductases with low molecular weight achieve quaternary
structure by utilizing the subunit-aggregating phenomenon.
The hog thymus reductase consists probably of a single
polypeptide chain based on its low molecular weight.
FHg reductase from hog thymus, like its counterpart
from most animal tissues (90), was stimulated 2-3 fold by
chaotropic agents. The activating agent is envisioned as
inducing some type of conformational change in the protein
(91). From the evidence that the activated enzymes are
more susceptible to proteolytic digestion or to heat dé
naturation (92), the transition is suggested likely that
from a compact to an unfolded form.
p-Chloromercuribenzoate, a modifier of sulfhydryl
groups, was shown to inhibit the hog thymus reductase in
agreement with results reported for the calf thymus enzyme
(6l) and that purified from S. faecalis R (34). FH^ re
ductases from chicken liver and 11210 cells, both of which
may be activated by pCMB, contain two cysteine residues
per molecule (87). Enzyme purified from 1. casei R fails
to be activated by pCMB and contains no cysteine residues
(88). From these experiments, it is believed that pCMB
reacts with the enzyme, probably via a protein sulfhydryl
groups this effect may result in a change in the
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conformation of the enzyme leading to enhanced or dimi
nished activity. Further investigation as to the possible
involvement of sulfhydryl groups and the mechanism of
mercurial action in hog thymus reductase appears to be
necessary.
Hog thymus reductase, like others from animal tissues,
showed double pH optima. Enzyme activity was slightly higher
at the alkaline pH value which is similar to that observed
for the human leukocytes enzyme (43»52). Chaotropic agents
changed the pattern of the pH-profile as presented in Figure
11. In the studies of chicken liver enzyme, Kaufman e_t al.
(50) reported a shift of the acid optimum from pH 4.0 to
4.5 with 2 M KOI present, whereas a single optimum was
observed at pH 6.4 in the presence of 2 M urea (93).
Methotrexate is the most potent reductase inhibitor
thus far known. As shown in Figure 12, 5 0 ^ inhibition was
— ft

achieved with less than 10”

M methotrexate at pH 7.2.

Changing the pH decreased the percent inhibition by the
folate antagonist. Werkheiser (58) introduced the techniques
of titrating reductase with the drug which requires that
enzyme and inhibitor combine irreversibly in a stoichio
metric manner. Work from Bertino's laboratory (65) has
shown that the degree of enzyme-inhibitor interaction
depends upon the pH and the ionic environments at acid pH
values the binding tends to be stoichiometric while at
alkaline pH it becomes reversible.
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The reaction mechanism of PH^ reductase from hog thymus
is sequential based on initial velocity studies. This finding
is in agreement with studies on the enzyme from S. faecium
(9^), L1210 cells (95) and E. coli (96). The estimated
kinetic constants presented in Table 2 were obtained by
fitting the data to the equation for a sequential mecha
nism (81).
Product inhibition studies were performed in order to
differentiate among the several possible sequential mecha
nisms. Difficulties were encountered in some of these
experiments due to the instability of FH^ and the small
amount of purified enzyme. No data have been obtained with
FHj^ inhibition. A summary of the predicted and experimental
inhibition patterns, together with those reported from other
sources are listed in Table 3* As can be seen, significant
differences in mechanism distinguish the enzyme from each
other. Thus, minor differences at the active center or in the
structure of the enzyme are suggested by the kinetic analysis.
The type of sequential mechanism for hog thymus reductase
can not be proposed yet due to the lack of information on
FHji^ inhibition.
Replots of slope or intercept in Figures 15 and l6
versus concentrations of NADP appeared to be hyperbolic with
NADPH as the variable substrate, and parabolic with FH2 as
the variable substrate. A more detailed analysis of the
nonlinear kinetic data by computer programmes proposed by
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TABLE 3
PATTERNS OF PRODUCT INHIBITION FOR FHg REDUCTASE

A. Predicted Patterns for Some Sequential Mechanisms'
Inhibition by
NADP

Inhibition by
FH,.

Mechanism

NADPH
varied

NADPH
varied

Ordered, NADPH first^
Ordered, FHg first^
Random
Rapid equilibrium
The ore11-Chanc e^

C
NC
NC
C
NC

FHp
varied
NC
NC
NC
C
C

NC
NC
NC
C
C

™
8- .
varied
NC
C
NC
C
NC

B, Experimental Patterns
S. faecium (89)
mutant enzyme
C
wild type enzyme
C
L1210 murine lymphoma (90) c
c
E. coli enzyme (91)
Hog thymus enzyme
c

NC
NC?
NC
UC? NC?
NC

NC
—
C
NC
—

NC
—

C
C
-----

li At fixed nonsaturating concentrations of the second
substrate.
2 1 NADPH reacted first and NADP released last
3* FHg reacted first and FH^ released last
4* FHg reacted first and NADP released last
The abbreviations used are *
C* competitive, NC» noncompetitive, UCi uncompetitive
— % information not available
?i uncertainty
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Cleland (97) is required to clarify the reaction mechanism.
The results of this investigation, as well as those
from others, have illustrated that FH^ reductase from
animal and bacterial sources differs with respect to its
physical and chemical properties. The enzymes have been
shown to differ in size, pH optimum, reaction mechanism,
and sensitivity to chaotropic agents, mercurials, inhibitors.
These differences, although small in nature, are the basis
of a rational development of new chemotherapeutic agents
capable of specially inhibiting the FH^ reductase in
abnormal cells, while having little or no effect on the
enzyme in normal cells.
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CHAPTER V
SUMMARY
Dihydrofolate reductase has been purified about 1,000
fold with an overall yield of 5 ^ from hog thymus glands.
The purification procedure includes addition of protamine
sulfate, ammonium sulfate precipitation, Sephadex G-lOO
filtration, affinity chromatography on methotrexateSepharose and Sephadex G-25 filtration. The purified enzyme
fraction was stable when kept frozen over several months.
It existed as a single electrophoretic form and with a
molecular weight 19,600 t 3,000 as estimated by Sephadex
G-lOO filtration.
About 2-3 fold increase in the catalytic activity of
the hog thymus reductase was achieved by chaotropic agents,
and the enzyme was inhibited by p-chloromercuribenzoate
-6

over the concentration range 5 x 10"

_o

to 1 x 10"-^ M. Double

pH optima, one between pH 5*0 and 5*5 and another near pH
7.5 were observed. Higher enzyme activity was observed at

the latter value. The presence of salts changed the pHactivity profile of dihydrofolate reductase.
FHg reductase from hog thymus was very sensitive to
Q
methotrexate. At pH 7.2, a drug concentration of 10” M was
sufficient to cause greater than 50 % inhibition of enzyme
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5^

activity. The degree of inhibition by this antifolate drug
was dependent upon the pH, Binding of methotrexate to the
enzyme was reversible.
The enzyme reaction follows a sequential mechanism.
Competitive inhibition was observed for NADP with respect
to NADPH, whereas noncompetitive inhibition was obtained
for NADP with respect to FH^ according to Cleland*s method
of analysis of the kinetic data. The Michaelis constant for
NADPH was calculated to be 0.6

ai M

and a value of 0.8

yuM

was

obtained for PHg. A dissociation constant of 2.3 -uM for FH2
was also determined.
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